The Journal of Organic Chemistry
Note
1
yield), eluent PE/EtOAc (8:1, v/v); H NMR (400 MHz, CDCl3) δ
2H), 6.85 (d, J = 8.8 Hz, 2H), 5.10 (s, 2H) ppm. 13C{1H} NMR (100
MHz, CDCl3) δ 160.0, 139.1, 136.5, 134.8, 133.5, 133.0, 132.3 (C−F,
3JC−F = 8.7 Hz), 130.1, 128.8, 128.7, 128.3, 127.5, 126.7, 116.1 (C−F,
2JC−F = 21.8 Hz), 115.0, 70.1 ppm. IR (KBr) 2920, 2842, 2160
7.94 (d, J = 7.2 Hz, 4H), 7.58 (t, J = 7.6 Hz, 2H), 7.43 (t, J = 7.6 Hz,
4H), 7.21 (t, J = 7.6 Hz, 1H), 7.09 (d, J = 8.8 Hz, 2H), 7.03−7.01 (m,
1H), 6.97−6.96 (m, 1H), 6.85−6.82 (m, 1H), 6.40 (d, J = 8.8 Hz,
2H), 3.89 (q, J = 6.8 Hz, 2H), 3.72 (s, 3H), 1.35 (t, J = 6.8 Hz, 3H)
ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 159.8, 159.3, 139.5, 136.7,
135.7, 134.1, 133.9, 133.1, 130.1, 129.3, 128.8, 127.0, 123.0, 116.0,
115.5, 114.0, 109.4, 63.4, 55.4, 14.7 ppm. IR (KBr) 2920, 2848, 2160
(SCN), 1602, 1508, 1379, 1259, 1168, 750 cm−1. HRMS (ESI), m/z:
calcd for C30H26KN2O6S3 [M + K]+: 645.0585, found: 645.0581.
N-(2-(2-Fluorophenyl)-1-(4-methoxyphenyl)-2-thiocyanatovin-
yl)-N-(phenylsulfonyl)benzenesulfonamide (2t). 2t was synthesized
following the general procedure B: white solid (44 mg, 74% yield,
mixture of 20:1 Z:E isomers), eluent PE/EtOAc (8:1, v/v); Z-isomer:
1H NMR (400 MHz, CDCl3) δ 7.96 (d, J = 7.2 Hz, 4H), 7.59 (t, J =
7.6 Hz, 2H), 7.45 (t, J = 7.6 Hz, 4H), 7.41−7.30 (m, 2H), 7.15 (d, J =
9.2 Hz, 2H), 7.14−7.02 (m, 2H), 6.44 (d, J = 9.2 Hz, 2H), 3.89 (q, J
= 7.2 Hz, 2H), 1.35 (t, J = 7.2 Hz, 3H,) ppm. 13C{1H} NMR (100
MHz, CDCl3) δ 159.7 (C−F, 1JC−F = 251.5 Hz), 159.7, 139.4, 138.1,
134.2, 132.5, 132.1 (C−F, JC−F = 8.2 Hz), 131.9 (C−F, JC−F = 1.3
Hz), 129.3, 128.9, 128.2, 126.7, 124.8 (C−F, JC−F = 3.2 Hz), 123.5
(SCN), 1600, 1508, 1379, 1259, 1168, 750 cm−1. HRMS (ESI), m/z:
calcd for C34H25KFN2O5S3 [M + K]+: 695.0541, found: 695.0539.
N-(2-Phenyl-1-(4-((pivaloyloxy)amino)phenyl)-2-thiocyanato-
vinyl)-N-(phenylsulfonyl)benzenesulfonamide (2x). 2x was synthe-
sized following the general procedure B: white solid (48 mg, 74%
yield, mixture of 8:1 Z:E isomers), eluent PE/EtOAc (8:1, v/v); Z-
isomer: 1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 7.2 Hz, 4H), 7.58
(t, J = 7.6 Hz, 2H), 7.45−7.41 (m, 6H), 7.31−7.29 (m, 3H), 7.06 (d,
J = 8.8 Hz, 2H), 6.88 (d, J = 8.8 Hz, 2H), 6.45 (s, 1H), 1.48 (s, 9H)
ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 152.2, 139.4, 139.0, 135.3,
135.2, 135.2, 134.2, 132.6, 130.4, 130.1, 129.3, 129.1, 128.9, 128.3,
117.3, 109.3, 81.1, 28.3 ppm. IR (KBr) 2926, 2852, 2160 (SCN),
1730, 1604, 1508, 1379, 1259, 1168, 750 cm−1. HRMS (ESI), m/z:
calcd for C32H33N4O6S3 [M + NH4]+: 665.1557, found: 665.1556.
N-(1-(4-Methoxyphenyl)-2-thiocyanato-2-(thiophen-2-yl)vinyl)-
N-(phenylsulfonyl)benzenesulfonamide (2y). 2y was synthesized
following the general procedure B: yellow solid (45 mg, 79% yield,
mixture of 8:1 Z:E isomers), eluent PE/EtOAc (8:1, v/v); Z-isomer:
1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 7.6 Hz, 4H), 7.59 (t, J =
3
4
4
2
2
(C−F, JC−F = 13.8 Hz), 116.5 (C−F, JC−F = 21 Hz), 114.0, 108.9,
63.5, 14.6 ppm. IR (KBr) 2920, 2850, 2158 (SCN), 1602, 1508, 1379,
1255, 1168, 750 cm−1. HRMS (ESI), m/z: calcd for C29H27FN3O5S3
[M + NH4]+: 612.1091, found: 612.1085.
7.6 Hz, 2H), 7.52−7.40 (overlap with E, 5H), 7.26−7.21 (m, 3H),
6.97−6.95 (m, 1H), 6.50 (d, J = 8.8 Hz, 2H), 3.72 (s, 3H) ppm.
13C{1H} NMR (100 MHz, CDCl3) δ 160.3, 139.4, 137.6, 135.5,
N-(1-(4-Phenoxyphenyl)-2-phenyl-2-thiocyanatovinyl)-N-
(phenylsulfonyl)benzenesulfonamide (2u). 2u was synthesized
following the general procedure B: white solid (42 mg, 67% yield,
mixture of 4:1 Z:E isomers), eluent PE/EtOAc (8:1, v/v); Z-isomer:
1H NMR (400 MHz, CDCl3) δ 7.98 (d, J = 8.0 Hz, 4H), 7.61 (t, J =
7.6 Hz, 2H), 7.49−7.40 (overlap with E, 7H), 7.36−7.29 (overlap
with E, 5H), 7.11 (d, J = 8.8 Hz, 2H), 6.91 (d, J = 7.6 Hz, 2H), 6.48
(d, J = 8.8 Hz, 2H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 158.0,
155.7, 139.5, 135.7, 135.3, 135.0, 134.2, 133.3, 130.5, 130.2, 129.9,
129.3, 129.1, 128.9, 128.3, 124.3, 119.7, 117.3, 109.4 ppm. E-isomer:
1H NMR (400 MHz, CDCl3) δ 7.76−7.74 (m, 2H), 7.63−7.59
134.1, 133.3, 132.1, 130.4, 129.2, 128.9, 127.7, 127.2, 126.1, 114.8,
109.4, 55.3 ppm. E-isomer: 1H NMR (400 MHz, CDCl3) δ 8.01 (d, J
= 7.6 Hz, 4H), 7.63 (t, J = 7.2 Hz, 2H), 7.52−7.40 (overlap with Z,
6H), 7.05−7.03 (m, 1H),6.93 (d, J = 8.8 Hz, 2H), 6.71−6.70 (m,
1H), 6.52−6.47 (m, 1H), 3.84 (s, 3H) ppm. 13C{1H} NMR (100
MHz, CDCl3) δ 161.5, 139.4, 138.5, 135.3, 134.4, 132.8, 132.1, 129.4,
129.1, 129.0, 128.2, 127.4, 126.8, 113.7, 109.3, 55.4 ppm. IR (KBr)
2920, 2848, 2160 (SCN), 1602, 1379, 1259, 1168, 750 cm−1. HRMS
(ESI), m/z: calcd for C26H20KN2O5S4 [M + K]+: 606.9887, found:
606.9882.
(overlap with Z, 2H), 7.49−7.40 (overlap with Z, 4H), 7.36−7.29
(overlap with Z, 3H), 7.25−7.12 (m, 5H), 7.15 (d, J = 7.2 Hz, 4H),
7.07 (d, J = 8.0 Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H) ppm. 13C{1H}
NMR (100 MHz, CDCl3) δ 159.2, 155.6, 139.1, 135.0, 134.2, 133.5,
133.5, 133.1, 130.3, 130.1, 130.1, 129.2, 129.0, 128.9, 128.6, 124.5,
120.0, 117.7, 108.8 ppm. IR (KBr) 2922, 2850, 2160 (SCN), 1585,
1504, 1484, 1379, 1274, 1168, 750 cm−1. HRMS (ESI), m/z: calcd for
C33H28N3O5S3 [M + NH4]+: 642.1186, found: 642.1180.
N-(1-(4-(Benzyloxy)phenyl)-2-phenyl-2-thiocyanatovinyl)-N-
(phenylsulfonyl)benzenesulfonamide (2v). 2v was synthesized
following the general procedure B: white solid (40 mg, 63% yield,
mixture of 20:1 Z:E isomers), eluent PE/EtOAc (8:1, v/v); Z-isomer:
1H NMR (400 MHz, CDCl3) δ 7.92 (d, J = 7.6 Hz, 4H,), 7.53 (t, J =
7.6 Hz, 2H), 7.45−7.30 (m, 14H), 7.07 (d, J = 8.8 Hz, 2H), 6.47 (d, J
= 8.8 Hz, 2H), 4.93 (s, 2H) ppm. 13C{1H} NMR (100 MHz, CDCl3)
δ 159.0, 139.4, 136.5, 135.4, 134.5, 134.1, 133.3, 132.0, 130.5, 130.0,
129.2, 129.1, 128.8, 128.7, 128.2, 127.4, 127.3, 114.4, 109.4, 69.8
ppm. IR (KBr) 2922, 2850, 2156 (SCN), 1597, 1508, 1458, 1377,
1274, 1166, 750 cm−1. HRMS (ESI), m/z: calcd for C34H26KN2O5S3
[M + K]+: 677.0635, found: 677.0626.
N-(2-(4-Acetylphenyl)-1-(4-methoxyphenyl)-2-thiocyanatovin-
yl)-N-(phenylsulfonyl)benzenesulfonamide (2za). 2za was synthe-
sized following the general procedure B: yellow solid (48 mg, 79%
yield, mixture of 4:1 Z:E isomers), eluent PE/EtOAc (8:1, v/v); Z-
isomer: 1H NMR (400 MHz, CDCl3) δ 7.96 (d, J = 7.6 Hz, 4H), 7.92
(d, J = 8.4 Hz, 2H), 7.62 (t, J = 7.6 Hz, 2H), 7.58 (d, J = 7.6 Hz, 2H),
7.47 (t, J = 8.0 Hz, 4H), 7.10 (d, J = 9.2 Hz, 2H), 6.44 (d, J = 9.2 Hz,
2H), 3.71 (s, 3H), 2.60 (s, 3H) ppm. 13C{1H} NMR (100 MHz,
CDCl3) δ 197.2, 160.3, 140.1, 139.3, 137.6, 137.3, 134.3, 133.5, 130.8,
130.4, 129.2, 128.9, 128.3, 126.6, 113.7, 109.1, 55.3, 26.7 ppm. E-
1
isomer: H NMR (400 MHz, CDCl3) δ 7.86−7.79 (m, 4H), 7.63−
7.60 (overlap with Z, 2H), 7.49−7.43 (overlap with Z, 6H), 7.19 (t, J
= 7.6 Hz, 4H), 6.82 (d, J = 8.8 Hz, 2H), 3.87 (s, 3H), 2.60 (s, 3H)
ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 197.0, 161.1, 139.1, 138.5,
137.8, 136.3, 133.1, 132.6, 131.9, 128.9, 128.7, 126.3, 114.2, 108.7,
55.5, 26.7 ppm. IR (KBr) 2921, 2848, 2158 (SCN), 1685, 1603, 1509,
1379, 1260, 1169, 750 cm−1. HRMS (ESI), m/z: calcd for
C30H25N2O6S3 [M + H]+: 605.0869, found: 605.0863.
N-((1E,3E)-1-(4-Methoxyphenyl)-4-phenyl-2-thiocyanatobuta-
1,3-dien-1-yl)-N-(phenylsulfonyl)benzenesulfonamide (2zb). 2zb
was synthesized following the general procedure B: yellow solid (43
mg, 73% yield, mixture of 1:12 Z:E isomers), eluent PE/EtOAc (8:1,
N-(1-(4-(Benzyloxy)phenyl)-2-(4-fluorophenyl)-2-thiocyanato-
vinyl)-N-(phenylsulfonyl)benzenesulfonamide (2w). 2w was synthe-
sized following the general procedure B: white solid (54 mg, 84%
yield, mixture of 2.6:1 Z:E isomers), eluent PE/EtOAc (8:1, v/v); Z-
isomer: 1H NMR (400 MHz, CDCl3) δ 7.91 (d, J = 7.6 Hz, 4H), 7.53
(t, J = 7.6 Hz, 2H), 7.47−7.35 (overlap with E, 11H), 7.05 (d, J = 8.4
Hz, 2H), 7.01 (t, J = 8.4 Hz, 2H), 6.50 (d, J = 9.2 Hz, 2H), 4.95 (s,
1
v/v); E-isomer: H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 7.6 Hz,
4H), 7.46 (d, J = 9.2 Hz, 2H), 7.29 (t, J = 7.6 Hz, 2H), 7.20−7.16 (m,
7H), 7.04 (d, J = 15.6 Hz, 1H), 6.99 (d, J = 6.8 Hz, 2H), 6.73 (d, J =
8.8 Hz, 2H), 6.63 (d, J = 15.6 Hz, 1H), 3.77 (s, 3H) ppm. 13C{1H}
NMR (100 MHz, CDCl3) δ 161.1, 139.7, 139.1, 137.9, 135.3, 133.9,
133.2, 129.4, 129.2, 128.8, 128.7, 128.5, 127.7, 127.3, 123.4, 113.9,
109.3, 55.5 ppm. IR (KBr) 2920, 2842, 2157 (SCN), 1653, 1602,
1506, 1379, 1258, 1170, 752 cm−1. HRMS (ESI), m/z: calcd for
C30H24N2NaO5S3 [M + Na]+: 611.0740, found: 611.0746.
2H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 163.3 (C−F, 1JC−F
=
250.6 Hz), 159.1, 139.4, 136.4, 135.8, 134.2, 134.0, 133.3, 132.7,
3
4
132.6 (C−F, JC−F = 8.6 Hz), 131.4 (C−F, JC−F = 3.4 Hz), 129.2,
128.8, 128.2 (C−F, 4JC−F = 2.3 Hz), 127.4, 127.1, 116.4 (C−F, 2JC−F
1
= 22.0 Hz), 114.5, 109.3, 69.8 ppm. E-isomer: H NMR (400 MHz,
(Z)-1-(4-Ethoxyphenyl)-2-phenyl-2-thiocyanatoethen-1-amine
(3o). 3o was synthesized following procedure C: white solid (420 mg,
81% yield), eluent PE/EtOAc (4:1, v/v); 1H NMR (700 MHz,
CDCl3) δ 7.72−7.68 (m, 2H), 7.57 (d, J = 8.8 Hz, 2H), 7.47−7.35
(overlap with Z, 11H), 7.18 (t, J = 8.0 Hz, 4H), 6.90 (t, J = 7.2 Hz,
5333
J. Org. Chem. 2021, 86, 5327−5335